Drug Database
Back to search

Switzerland· 55970002

Micardis Plus 80/12,5 mg, Tabletten

A telmisartan und diuretika product, registered in Switzerland by Boehringer Ingelheim (Schweiz) GmbH and dispensed under Swissmedic category B. The same ATC class is registered in 13 of our 19 countries.

Cat B (Swissmedic)ATC C09DA07

Checked against the register on

Informational only — not a medical device.

SOURCE REGISTER · CHPublic registernormalisedMicardis Plus 80/12,5 mg, TablettenATCC09DA07REGISTER NO.55970002PACKS LISTED0CHECKEDJune 26, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about MicardisAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Telmisartan und diuretika is registered in 13 of 19 countries.

Countries holding a registration under ATC C09DA07 (telmisartan und diuretika), each read from that country’s own register.

  • This record: Switzerland
  • 9 of them publish a price we can compare per daily dose
Search telmisartan und diuretika products by name

Telmisartan und diuretika · ATC C09DA07

13 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Manufacturer
Boehringer Ingelheim (Schweiz) GmbH
Country
Switzerland (CH)
ATC code
C09DA07
ATC class
Telmisartan und Diuretika
Swissmedic category
B
Reimbursed
No
Last checked
June 26, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

80 interactions on record for telmisartan und diuretika.

Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check telmisartan und diuretika against other medicinesHow interaction checks work

Telmisartan und diuretika · interactions on record

80 records

80 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
Mechanism and what to do, in the interaction check
Interaction register. Grades as the source publishes them.

Same class

Other records under C09DA07

Telmisartan und diuretika, as other registers publish it.

All telmisartan und diuretika products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of the issuing authority. This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/d8f369be-eab5-4527-89c2-7f78d5bf6427
GET /v1/drugs/d8f369be-eab5-4527-89c2-7f78d5bf6427?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "source": "swissmedic_auth",
  "heilmittelcode": "Synthetika"
}
API referenceMCP serverPlans

See everything about telmisartan und diuretika.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console